semaglutide long term icd 10 glp 1 icd 10 ICD-10-CM Diabetes Coding Guidelines Simplified Semaglutide dose may matter more

However, dizziness may occur, particularly while the dose is being increased

Liu C, Wu T, Ren N (2023) Glucagon-like peptide-1 receptor agonists for the management of diabetic peripheral neuropathy

baseline, 2000)

On the other hand, a recent network meta-analysis [32] indirectly compared CV effects among different GLP-1RA in patients with T2DM and did not find any significant difference between GLP1RA in reducing death from any cause, MI and stroke events

Gastrointestinal side effects caused 5.6% of semaglutide patients to stop their medication entirely, compared to only 2.7% of tirzepatide patients.[1] That's roughly half the dropout rate due to GI issues